Opinion: Billions of Tax Dollars will be Saved by Drug Price Negotiation in the Inflation Reduction Act – The Virginian-Pilot

TL/DR –

The Inflation Reduction Act’s drug price negotiation provision could potentially save US taxpayers billions of dollars, according to an op-ed in The Virginian-Pilot. The Act, which will prevent pharmaceutical companies from raising prices faster than inflation, is expected to save the government $456 billion over ten years, according to the Congressional Budget Office. The author also argues that the Act will help address health disparities by making medications more affordable for low-income Americans.

How the Inflation Reduction Act Can Save Billions Through Drug Price Negotiation

For those interested in the potential savings that could come from a change in drug pricing, the Inflation Reduction Act’s drug price negotiation is noteworthy. This act is set to save taxpayers billions of dollars, a significant ease on the public purse. In the current economic context, any savings are indeed welcome.

Read More US Economic News